2m 2m 2m 2m 2m 2m 2m
CDT EQUITY (CDT)
NASDAQ
$3.00+$0.14 (+4.72%)
Price as of Aug 21, 2026 7:57 PM EDT- $2.2MMarket Cap
- -99.91%1-Year Change
- BiotechnologyIndustry
CDT EQUITY (CDT)
$3.00+$0.14 (+4.72%)
CDT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.86 | ||
Change | -$0.04 (-1.38%) | ||
Open | $2.99 | ||
High | $3.40 | ||
Low | $2.84 | ||
Previous Close | $2.90 | ||
Volume | 81,262 | ||
30-Day Average Volume | 64,760 | ||
1-Week Change | -2.05% | ||
1-Month Change | -25.33% | ||
1-Year Change | -99.91% | ||
3-Year Change | -100.00% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 786,670 | ||
Total Assets | $126.7M | ||
Market Cap | $2.2M | ||
Enterprise Value | $1.5M | ||
Period: QTR TTM FY | |||
Revenue | $341,000.00 | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$544,000.00 | ||
EBIT | -$4.7M | ||
EBITDA | -$4.6M | ||
Net Working Capital | -$20.4M | ||
EPS | -$87.10 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 4 | ||
P/B | N/A | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/20/2026 | ||
Earnings & Revenue